Discover a study on psoriasis treatment failure, highlighting when to move from topical therapies to systemic care for ...

Treatment with GLP-1 RAs was linked to decreased risks for all-cause mortality and MACE in patients with psoriasis when compared with other antidiabetic or obesity drugs.

Anti-IL-17A biologics have the greatest odds of achieving and maintaining clear or almost clear skin among patients with psoriasis.

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of plaque ...

A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionize how ...

For the 7.5 million Americans diagnosed with psoriasis, it can be disheartening to hear that there's no cure. But there are several treatments that can help keep this autoimmune disease under control.

The advantage of earlier treatment was evident in patients who achieved so-called "super-responder" status and those who did ...

Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, announces ...

The skin is the largest organ in the human body. Its softness allows for movement and flexibility, yet it is also durable enough to typically resist breaking or tearing. As one of the body’s more ...

A 16-week Mediterranean Diet intervention led to significant improvements in disease severity among patients with psoriasis.

Psoriasis may not have a cure, but new research has found that significant relief could be achieved at the dinner table. In a ...